# The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

> **NCT03188276** · EARLY_PHASE1 · COMPLETED · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 52 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Ledipasvir-Sofosbuvir
- **DRUG:** Daclatasvir-Sofosbuvir

## Key facts

- **NCT ID:** NCT03188276
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-01
- **Primary completion:** 2017-05-01
- **Final completion:** 2017-05-01
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2017-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03188276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03188276, "The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03188276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*